Sign in
Taking people in South AfricaNo phase

Testing Urine for HPV to Screen for Cervical Cancer in Women With HIV

Checks whether urine samples can detect cervical cancer risk in women living with HIV.

Key facts

Who runs it
UNC Lineberger Comprehensive Cancer Center
Where
Westdene, South AfricaSee the site
Trial code
Registry title
Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
Status
Recruiting
People taking part
300 people, planned
Started
11 May 2023
Expected to end
Aug 2027
Type of study
Interventional
Treatments tested
  • Urine HPV testing
  • Self-collected cervicovaginal specimen
  • Provider-collected cervical samples
Record updated
30 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women living with HIV-1 who are 25 or older. It tests whether urine samples can be used to screen for cervical cancer.

Age
25 years and older
Sex
Women only
Earlier treatment
Cannot have been screened for cervical cancer in the past year (365 days). Cannot have had an HPV vaccine.
Biomarker or test result
Confirmed HIV-1 infection

Main reasons for not taking part

  • Pregnant, or planning to become pregnant within 90 days of enrollment
  • Screened for cervical cancer within the past year (365 days)
  • Active sexually transmitted infection (can join once treated)
  • Cervix removed by surgery
  • History of cervical cancer

This trial only enrols participants living with HIV. The registry sentence this rests on: Confirmed HIV-1 infection

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • In order to participate in this study a subject must meet all of the eligibility criteria outlined below
  • Confirmed HIV-1 infection
  • Age 25 years and older
  • Be willing and able to provide written informed consent

Who cannot take part

  • Have been screened for cervical cancer within the preceding year (365 days)
  • Have an active sexually transmitted infection (STI; women may participate once treated)
  • Have a history of cervical cancer
  • Pregnant or intend to become pregnant within 90 days of enrollment
  • Have a surgically absent cervix
  • have been vaccinated against HPV

This trial is currently available in South Africa.

  • Clinical HIV Research Unit Temba Lethu Wing Helen Joseph HospitalWestdene, South AfricaContact: Sibusisiwe LuvunoTaking people

About the trial

What the trial wants to find out

The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women.

Read full original descriptionShow less

Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that lead to cervical precancer and, eventually, cervical cancer if untreated. However, urine HPV testing has not been well validated low- and middle-income country settings, with no data available to guide its use in HIV-infected women.

The group in the trial

  • Single ArmOther group

    This is a single arm study. All participants will receive same interventions.

    Treatment: Urine HPV testing, Self-collected cervicovaginal specimen, and Provider-collected cervical samples

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Performance Validation of Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
Plain-language title
Testing Urine for HPV to Screen for Cervical Cancer in Women With HIVGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 September 2026